Critical congenital heart defects (CCHDs) are serious malformations that are an important cause of neonatal mortality and morbidity. The clinical presentations of CCHD are shock, cyanosis, or respiratory distress, which may be similar to that of other neonatal conditions.
Failure to diagnose these conditions early on after birth may result in acute cardiovascular collapse and death. Simple screening methods have been found to be efficient in distinguishing newborns with CCHD and other hypoxemic illnesses, which may otherwise be potentially life-threatening. Risk factors, symptoms, screening methodologies and indications, and proper management strategies will be discussed.
Learning Objectives:
1) List 2 key findings that are indications for screening for critical congenital heart disease (CCHD) in the fetal and neonatal period.
2) Describe available screening methods for diagnosing CCHD in the fetus or newborn.
3) Explain the differential diagnosis and management of CCHD in the fetus or newborn.
To Continue, Please Select Your Country of Residence
Whoops! Please select your Country before clicking "Submit"
The GOLD Learning Lecture Library is a unique & convenient resource for Healthcare Professionals, Researchers, Students and other Educators looking to stay up to date on the latest evidence-based skills and practices. Country Category pricing has been determined by World Bank Economic Indicators. Proof of residency may be requested. Learn more about our Category Pricing Here.
